Genitourinary Cancer News

The FDA approved bevacizumab-adcd for treatment of six cancer types, according to a press release from the biosimilar’s manufacturer.

Consumption of sugar-sweetened beverages appeared associated with increased risk for death from an obesity-related cancer, according to study results published in Cancer Epidemiology, Biomarkers & Prevention.

Anxiety and depression that may follow a cancer diagnosis, especially as a patient approaches the end of life, can be incapacitating and difficult to assuage.

As a nurse, Brianne “Bree” Duncan, RN, BSN, has always had the goal to help and make a difference in her patients’ lives.

The combination of nivolumab and ipilimumab after nephrectomy failed to extend DFS among patients with localized renal cell carcinoma at high risk for relapse, results of the phase 3 CheckMate 914 trial showed.

This year’s European Society for Medical Oncology Congress featured potentially practice-changing research in kidney cancer, cutaneous squamous cell carcinoma, lung cancer and melanoma.

The FDA approved sodium thiosulfate to reduce risk for cisplatin-associated ototoxicity among certain children with cancer.

It is well known that obesity, physical inactivity and a poor diet increase the risk for various cancer types and contribute to adverse outcomes among adults with certain malignancies.

A novel multicancer early detection blood test identified a common signal for more than 50 cancer types and predicted where the signal originated in the body among individuals with undiagnosed cancer.

Cabozantinib plus nivolumab and ipilimumab conferred a significant PFS benefit vs. nivolumab and ipilimumab alone among patients with advanced renal cell carcinoma, according to results of the COSMIC-313 trial presented at ESMO Congress.